Minoxidil, a pyrimidine derivative (2,4-diamino-6-piperidino-pyrimidine-3-oxide) is an adenosine triphosphate (ATP) sensitive potassium chennel (K ATP chennel) opener, and is the most commonly used drug for the treatment of androgenetic alopecia.
The Additive Effects of Minoxidil and Retinol on Human Hair Growth in Vitro
used, as described previously.
11)
Human Hair Follicle Organ Culture Human scalp hair follicles were isolated and cultured in vitro, as described previously. 12) Briefly, dissected hair follicles were cut individual into small pieces of approximately 2.5 mm in length from the bottom of the dermal papilla, and then cultured in Williams E medium (Gibco BRL, Gaithersburg, MD, U.S.A.) containing 10 ng/ml hydrocortisone, 10 mg/ml insulin, 2 mM L-glutamine, and 100 U/ml penicillin at 37°C in a 5% CO 2 atmosphere. Minoxidil and retinol were added to this culture medium alone or in combination. Minoxidil was treated at final concentrations ranging from 1 to 10 mM, and retinol was used at concentrations from 17 nM to 1.7 mM. The individual inhibitors and the concentrations were used U0126 at 20 mM and LY294002 at 50 mM. A total of 30 anagen hair follicles (3 different volunteers and 10 follicles per individual) were used per each test condition, and this was performed in triplicate. Data are presented as the means of triplicate culturesϮS.E.M. In all experiments, tissue culture medium containing minoxidil and/or retinol was changed every other day. After culturing for 12 d, hair follicle elongation was measured directly using an Olympus stereomicroscope with an eyepiece containing a graticule.
Culture of Human DPCs and HaCaT DPCs were cultured as described previously. 13) Briefly, cells were cultured in Dulbecco's modified Eagle's medium (Gibco BRL, Gaithersburg, MD, U.S.A.) containing 2 mM L-glutamine, 1ϫ antibiotic antimycotic solution (1000 mg/ml of streptomycin sulfate, 1000 units/ml of penicillin G sodium, and 2.5 mg/ml of amphotericin B) and 10% fetal bovine serum (FBS; Hyclone, Logan, UT, U.S.A.) at 37°C, in a 5% CO 2 incubator. Fourth-passage DPCs were used. On the other hand, HaCaT were incubated in DMEM supplemented with 10% fetal bovine serum (Hyclone, Logan, UT, U.S.A.), 1 mM sodium pyruvate, 50 mg/ml streptomycin and 100 U/ml penicillin at 37°C in 5% CO 2 .
Thiozolyl Blue [3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyl Tetrazolium Bromide] (MTT) Assay Cell viabilities were determined using MTT assays. Briefly, DPCs and HaCaT cells at 1.5ϫ10 4 cells/well were seeded into 96-well plates, cultured for 24 h in serum-free DMEM, and then treated with vehicle (0.12 mM HCl or DMSO diluted 1 : 1000 in serum-free DMEM) as a control, minoxidil (0.01 mM), retinol (1.7 pM-1.7 nM), or minoxidil (0.01-1.0 mM) plus retinol (1.7 pM-1.7 nM) for 5 d. HaCaT cells were mocktreated (control), or pre-treated with 10 mM LY, 10 mM U, 200 nM W for 2 h and then were as above treated with the indicated concentration of monoxidil plus retinol. Twenty microliters of MTT solution (5 mg/ml) was added per well and incubated for 3 h at 37°C in the dark. The supernatant was then removed, and the formazan crystals were dissolved in 200 ml of DMSO. The samples were incubated for 30 min at room temperature, and quantified by measuring optical density at 540 nm using an ELISA reader (TECAN, Salzburg, Austria). Results are expressed as percentages of control cells; experiments were performed 8 times.
Trypan Blue Exclusion Assays To evaluate the effects of minoxidil and retinol alone or in combination on the viability and proliferation of HaCaT, the percentages of viable cells were determined by trypan blue staining. HaCaT cells were seeded into 96-well plates at 1.5ϫ10 4 cells/well, cultured for 24 h in serum-free DMEM, and treated with the vehicle (0.12 mM HCl/DMSO diluted 1 : 1000 in serum-free DMEM) as control, minoxidil (0.01 mM), retinol (1.7 pM-1.7 nM), or minoxidil (0.01-1.0 mM) plus retinol (1.7 pM-1.7 nM) for 5 d. Cell growths and viabilities were measured by adding 0.4% trypan blue in 0.9% saline to a 50% dilution, and cells were counted using a hemocytometer. Western Blot Confluent DPCs and HaCaT were incubated for 24 h treated with vehicle, minoxidil (0.01 mM), retinol (1.7 pM), or 0.01 mM minoxidil plus 1.7 pM retinol for 1 h to evaluate Erk and Akt expression and for 24 h to evaluate Bcl-2/Bax ratios and b-actin expression. Cells were washed twice with ice-cold phosphate-buffered saline (PBS) and then extracted with an extraction buffer (1% NP-40, 1 mg/ml aprotinin, and 400 mM NaCl in 20 mM HEPES, pH 7.2). Soluble extracts were prepared by centrifugation at 15000 rpm for 15 min at 4°C, and protein levels were quantified using BCA protein assay kits (Pierce, IL, U.S.A.). Protein (50 mg) was loaded into 10% or 12% SDS-polyacrylamide gels, separated by electrophoresis, and blotted onto nitrocellulose membranes. Blotted membranes were incubated with primary antibody (anti-Erk polyclonal antibody, 1 : 500; anti-phosphorylated Erk polyclonal antibody, 1 : 500; antiAkt polyclonal antibody, 1 : 500; anti-phosphorylated Akt polyclonal antibody, 1 : 500; anti-Bcl-2 monoclonal antibody, 1 : 1000; anti-Bax monoclonal antibody, 1 : 1000; anti-b-actin monoclonal antibody, 1 : 1000) at 4°C overnight. Membranes were then incubated with anti-mouse IgG-HRP conjugate (1 : 2000) or anti-rabbit IgG-HRP conjugate (1 : 2000) for 1 h at room temperature. The antibody-antigen complex was detected using an ECL system (Amersham Pharmacia Biotech; Little Chalfont, U.K.) and analyzed using a Bio-Rad GS-700 imaging densitometer (Hercules, CA, U.S.A.).
Terminal Deoxynucleotidyl Transferase-Mediated dUTP Nick End-Labeling (TUNEL) Assays To measure the number of apoptotic cells, we used a commercially available TUNEL kit (ApopTag plus peroxidase in situ apoptosis detection kit, Chemicon, U.S.A.). Cells were fixed in 1% paraformaldehyde (10 min at RT), washed with PBS, incubated with equilibration buffer (1 min at RT), then with TdT enzyme for 1 h at 37°C. Cells were then washed using a stop wash solution for 10 min at RT, and incubated with digoxigenin-dUTP for 1 h at room temperature. AEC (3-amino-9-ethylcarbazole, Zymed, U.S.A.) was used as a color-developing reagent and cells were counterstained by Mayer's hematoxylin (Dako, U.S.A.) and mounted with aqueous mounting solution (Dako, U.S.A.). Cells were then examined under a light microscope at ϫ200.
Statistical Analysis Statistical analyses were performed using the Student's t-test or multivariate ANOVA for parametric analyses. P-values of less than 0.05 were considered statistically significant.
RESULTS

Minoxidil Plus Retinol Enhances Human DPCs and
HaCaT Proliferations to a Greater Extent Than Minoxidil or Retinol Alone Minoxidil (0.01 mM) plus retinol (1.7 pM-1.7 nM) significantly increased the proliferation of human DPCs compared with the vehicle-treated control, and the cells proliferated more efficiently in 0.01 mM minoxidil in combination with 1.7 pM or 17 pM retinol than minoxidil alone (p<0.05). The enhancement was greatest at 0.01 mM minoxidil plus 17 pM retinol (Fig. 1A) . Proliferation of vehicle treatment for 5 d was slightly increased about 115% compared with vehicle control at 0 h (statistically not significant, data not shown). Minoxidil (0.01 mM) or the lower concentrations of retinol (1.7 pM or 17 pM) alone enhanced the proliferation of HaCaT significantly compared with the control. The effect of minoxidil (0.01 mM) plus retinol (1.7 pM) on the proliferation of HaCaT was significantly greater than that of minoxidil alone. The proliferation of HaCaT was suppressed significantly by the higher concentration of retinol (17 nM) alone or retinol (1.7 nM or 17 nM) plus minoxidil (0.01 mM) compared with the control (Fig. 1B) . The trypan blue exclusion assays produced results that were very similar to those of the MTT assay (Fig. 1C) . In cultured human HaCaT, the pretreatment of inhibitors (U0126, LY294002 and Wortmannin) demonstrated statistically significant decrease of cell proliferations compared with minoxidil plus retinol-treated condition (Fig. 1D) .
Minoxidil Plus Retinol Increased the Phosphorylation of Erk More Effectively Than Minoxidil or Retinol Alone
Phosphorylated Erk (p-Erk) levels were significantly increased in DPCs and HaCaT treated with minoxidil (0.01 mM) for 1 h compared with vehicle control to 241Ϯ63% (p<0.01) and 133Ϯ22% (p<0.05), respectively. Retinol also significantly increased p-Erk levels compared with vehicle control to 343Ϯ113% (p<0.01) and 149Ϯ27% (p<0.01) in DPCs and HaCaT, respectively. Moreover, treatment of minoxidil plus retinol significantly increased the pErk compared with vehicle control to 556Ϯ178% (p<0.001) and 204Ϯ30% (p<0.01) (Figs. 2A, B) . However, total Erk levels in both cells were barely changed in response to the various treatments. The values shown in Fig. 2 are percentages of control values from five different trials. In the time course of the p-Erk activities, we confirmed that p-Erk level showed at the peak time of 1 h in HaCaT (Fig. 2C) . To identify the relation between specific signaling pathways in HaCaT, we pretreated U0126 (10 mM) and found that it had significantly reduced p-Erk expression as compared with minoxidil plus retinol. Pretreatment of PI3-kinase inhibitor, LY294002 (10 mM) was unable to change the p-Erk level (Fig. 2D) .
Minoxidil Plus Retinol Increased the Phosphorylation of Akt More Effectively Than Minoxidil or Retinol Alone
In DPCs and HaCaT, minoxidil significantly elevated phosphorylated Akt (p-Akt) to 272Ϯ37% (p<0.01) and 146Ϯ37% (p<0.05) compared with the control, respectively. Minoxidil plus retinol significantly increased the p-Akt activities in these two cells to 481Ϯ146% (p<0.01) and 198Ϯ23% (p<0.01), respectively, whereas retinol alone was 394Ϯ88% (p<0.01) and 180Ϯ26% (p<0.01) (Figs. 3A, B) . As a result of determination of time dependent activity of p-Akt, the peak activation was also shown at 1 h in HaCaT (Fig. 3C) . Pretreatment of PI-3 kinase specific inhibitors, LY294002 (10 mM) and Wortmannin (200 nM) significantly reduced the activation of p-Akt versus co-treatment of minoxidil plus retinol in HaCaT (Fig. 3D) . The effect of U0126 was not obvious. The values shown are percentages of controls for five different batches of DPCs and HaCaT.
Minoxidil Plus Retinol Increased Bcl-2 Expression, But 
Decreased Bax Expression and TUNEL-Positive Cells More Than Minoxidil or Retinol Alone
To evaluate the possible association between cellular apoptotic property and changes in the expression of Bcl-2 family, we investigated the effects of minoxidil and/or retinol on the expression of Bcl-2 and Bax. The Bcl-2 expression was increased after treatment with minoxidil or retinol for 24 h. Minoxidil increased the Bcl-2 expression to 228Ϯ61% (p<0.01) and 115Ϯ12% (statistically not significant) in human DPCs and HaCaT, respectively, and retinol increased Bcl-2 expressions to 333Ϯ95% (p<0.01) and 148Ϯ15% (p<0.05), respectively. In addition, treatment of minoxidil plus retinol significantly elevated Bcl-2 expression to 386Ϯ86% (p<0.01) and 177Ϯ11% (p<0.01) in these two cell types versus the vehicle controls (Figs. 4A, B) .
In contrast, the expression of Bax was reduced after treatment with minoxidil alone to 70Ϯ14% (p<0.05) and 75Ϯ16% in human DPCs and HaCaT, respectively. Moreover, treatment of minoxidil plus retinol significantly reduced Bax expression to 28Ϯ3% (p<0.001) and 54Ϯ3% (p<0.01) versus vehicle controls, respectively (Figs. 4C, D) . As shown in Figs. 4E and F, TUNEL assays were carried out to determine whether minoxidil plus retinol could prevent against apoptosis. The number of apoptotic cells was decreased significantly after minoxidil plus retinol treatment, i.e. it was reduced to 24% (p<0.05) and 43% (p<0.01) compared with the vehicle control and minoxidil alone, respectively in HaCaT.
Minoxidil Plus Retinol Enhanced Hair Growth More Efficiently Than Minoxidil or Retinol Alone in Human
Hair Follicle Organ Culture Minoxidil significantly increased hair growth from 2.1Ϯ0.5 mm (vehicle control) to 3.2Ϯ0.4 mm at 1 mM (p<0.001) and to 3.0Ϯ0.4 mm at 10 mM (p<0.01), respectively. Retinol also tended to induce hair growth in a dose-dependent manner versus vehicle, but it was not statistically significant (Fig. 5A) . Retinol tended to induce hair growth in a dose-dependent manner compared with the control, but this was not statistically significant. Minoxidil (1 mM) plus retinol (17 nM) significantly increased hair growth more than minoxidil alone (1 mM) (p<0.001). However, the mixing effect of 1 mM minoxidil and 17 nM retinol 24 Vol. 30, No. 1 treatment was more effective than minoxidil or retinol alone on human hair follicle growth, although the elongation of hair follicles by the higher combination of the two was not less than minoxidil or retinol alone. To clarify the relationship between hair growth and the activation of signaling proteins, we pretreated with U0126 (20 mM) or LY294002 (50 mM) before treatment of minoxidil plus retinol. It was demonstrated that hair growth induced by minoxidil plus retinol was completely suppressed by those inhibitors (p<0.001) (Fig. 5B) .
DISCUSSION
We previously demonstrated that minoxidil significantly induced the proliferation of human DPCs at concentrations ranging from 0.01 to 1.0 mM. 10) Minoxidil was found to have a biphasic effect on the proliferation and differentiation of normal human keratinocytes (NHK), i.e. minoxidil stimulated NHK proliferation at micromolar doses, but had antiproliferativie, pro-differentiative and partially cytotoxic effects at millimolar concentrations. 14) In another study, ATRA (All-trans retinoic acid) at concentrations ranging from 0.01 to 1.0 mg/ml (34 pM-3.3 mM) stimulated the proliferations of fibroblasts and epithelial cells. 15) Retinol is a known anti-oxidant, and moreover, retinoids increase the rate of hair growth, prolong the anagen phase of the hair cycle, play a role in converting vellus to terminal hairs, and act in conjunction with minoxidil to produce denser hair re-growth from regressing follicles than either compound alone. 16) The role of the ERK signaling pathway is critical in mitogenesis and cell growth. 17, 18) Previous reports also suggested that Akt plays a critical role in mediating survival signals. [19] [20] [21] [22] In this study, minoxidil plus retinol was demonstrated to elevate the phosphorylations of Erk, Akt in cultured human DPCs and HaCaT, which could result in the increase of growth and survival of DPCs and HaCaT. In particular, the expression of p-Akt decreased in these cells after administrating U0126, which suggested that U0126 would have stronger suppressive effect on cell growth than LY294002 or Wortmannin (Fig. 3D) . A previous study re- ported that U0126 was caused by their cytotoxicity on the late time (50-70 h) and then decreased the p-Akt activity. 23) Minoxidil plus retinol was also shown to increase Bcl-2 and to decrease Bax expression in cultured DPCs and HaCaT. The Bcl-2 protein families constitute a critical intracellular checkpoint in the intrinsic pathway of apoptosis. The first proapoptotic homolog, Bax, was identified by its interaction with Bcl-2 24) and the Bcl-2/Bax ratio constitutes a measure of susceptibility to apoptosis via the intrinsic death pathway. 25) Buhl et al. reported that minoxidil stimulates hair growth of mouse vibrissae follicles in organ culture. 26) In a whole skin piece culture system from 4-week-old mice, 27) it also demonstrated that minoxidil promoted hair follicle elongation. Minoxidil causes telogen hair follicles to enter the anagen phase, and prolongs the anagen period, and thus increases hair follicle size. 1) In human hair follicle organ culture, minoxidil plus retinol induced more hair growth than minoxidil or retinol alone. These results suggest that minoxidil plus retinol could have an additive effect on human hair growth, and to the best of our knowledge this study is the first to evaluate the effects of the combination of minoxidil and retinol on hair growth using organ culture of human scalp hair follicles.
In summary, we have demonstrated in this study that hair growth was significantly enhanced by the combination of minoxidil plus retinol compared with minoxidil or retinol alone.
We suggest that the actual hair growth modulatory effects of the combination of minoxidil and retinol would be derived from different mechanisms, i.e. (i) via the activation of Erkand Akt-dependent pathways and (ii) via the prevention of apoptosis by increasing the Bcl-2/Bax ratio and the number of TUNEL negative cells. Thus, the combination of minoxidil and retinol provides as an efficient hair growth modulatory strategy for the administration on hair loss (alopecia) patients, which supports the possibility more effectively than existing minoxidil alone materials. 
